Jeffrey B. Landau, Chief Business Officer at CytomX Therapeutics, Inc. (CTMX), sold 4,077 shares at $1.38 ($6K) on 2023-12-20, disclosed to the SEC on 2023-12-22.
Open-market sale of $6k CTMX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTMX | SELL | 2023-09-22 | $5K | — | Filing → |
| CTMX | SELL | 2023-03-20 | $3K | — | Filing → |
| CTMX | SELL | 2022-07-21 | $6K | — | Filing → |